Hawkins Inc (HWKN)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Hawkins Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 7 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 132.10 $ — 18% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AAQS
7/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 9.4%
- Exp. sales growth 3Y > 5% 6.3%
- EBIT growth 10Y > 5% 12.9%
- Exp. EBIT growth 3Y > 5% 16.1%
- Net debt < 4x EBIT 2.2x
- EBIT positive, 10Y straight 9
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% 104.4%
- ROCE > 15% 12.8%
- Expected return > 10% 19.7%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 5.0% failed
- More than 10% revenue growth is expected for the coming year 5.4% failed
- Share count grows by less than 3% a year -0.2% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 19.2% failed
- Gross margin at 40% or higher and without meaningful erosion 20.7% failed
- Goodwill from acquisitions does not grow faster than revenue 22.3% failed
- Net debt below twice EBITDA 1.5 x EBITDA passed
- Operating cash flow covers the profits of the last three years 174 m passed
- Return on capital at 15% or higher, or up versus two years ago 12.8% failed
- Insiders hold at least 10% or are net buyers 8.5% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 34.4% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 2
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 03/31/2027 | 4.99 | 4.99 – 4.99 | 1,181 | 26.2% | 1 |
| 03/31/2028 | 5.27 | 5.18 – 5.35 | 1,224 | 5.5% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.72 | 1.10 | 226 | 8.50 | 6.60 | 21 | 12 |
| 2025: Q1 | 0.78 | 18.50 | 245 | 10.00 | 6.70 | 31 | 20 |
| 2025: Q2 | 1.40 | 1.50 | 293 | 14.60 | 9.90 | 32 | 18 |
| 2025: Q3 | 1.08 | -6.20 | 280 | 13.50 | 8.10 | 40 | 29 |
| 2025: Q4 | 0.69 | -4.60 | 244 | 7.90 | 5.90 | 36 | 21 |
| 2026: Q1 | 0.74 | -5.40 | 266 | 8.40 | 5.80 | 38 | 18 |
| 2026: Q2 | 1.35 | -3.60 | 316 | 7.60 | 9.00 | 35 | 24 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | 484 | 39 | 23 | 1.06 | 45 | 218 | 419 |
| 2018 | 504 | -12 | -9 | -0.43 | 27 | 202 | 391 |
| 2019 | 556 | 37 | 24 | 1.14 | 48 | 218 | 386 |
| 2020 | 540 | 42 | 28 | 1.33 | 59 | 233 | 396 |
| 2021 | 597 | 56 | 41 | 1.93 | 44 | 265 | 481 |
| 2022 | 775 | 71 | 52 | 2.44 | 43 | 303 | 567 |
| 2023 | 935 | 88 | 60 | 2.86 | 77 | 350 | 602 |
| 2024 | 919 | 104 | 75 | 3.59 | 160 | 406 | 673 |
| 2025 | 974 | 121 | 84 | 4.03 | 111 | 460 | 770 |
| 2026 | 1,084 | 115 | 82 | 3.91 | 144 | 534 | 1,002 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Hawkins, Inc. ist als Unternehmen für Wasseraufbereitung und Spezialzutaten in den USA tätig.
| Employees | 1,200 |
|---|---|
| Headquarters | Roseville, MN |
| Address | 2381 Rosegate, 55113 Roseville, United States |
| Phone | 612 331 6910 |
| Website | hawkinsinc.com |
| IPO Date | 27. Oct 1993 |
| ISIN | US4202611095 |
| Stock Split | 2:1 on 03/02/2021 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Patrick H. Hawkins | CEO, President & Director | 1971 |
| Jeffrey P. Oldenkamp | Executive VP, CFO & Treasurer | 1972 |
| Drew M. Grahek | Vice President of Operations | 1970 |
| Daniel J. Stauber | Director | 1962 |
| David J. Mangine | Vice President of Industrial Solutions | 1958 |
| Douglas A. Lange | Vice President of Water Treatment Group | 1970 |
| Daniel A. Louismet | VP, General Counsel & Secretary | 1986 |
| Paul Siler | Corporate Controller | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Tang Yi | Director | Other | 721 | 0.00 | – |
| 29. Jul 2026 | Spethmann Jeffrey E | Director | Other | 721 | 0.00 | – |
| 29. Jul 2026 | Stauber Daniel J | Director | Other | 721 | 0.00 | – |
| 29. Jul 2026 | Schumacher Mary J. | Director | Other | 721 | 0.00 | – |
| 29. Jul 2026 | Faulconbridge James A | Director | Other | 721 | 0.00 | – |
| 29. Jul 2026 | Thompson James T | Director | Other | 721 | 0.00 | – |
| 29. Jul 2026 | Wright Jeffrey L | Director | Other | 721 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.